Computational Immunology
Computational Immunology market is segmented by players, region (country), by Type and by Applica ... Read More
Global Immunoinformatics Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunoinformatics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Cancer Diagnosis & Therapy
1.2.3 Reverse Vaccinology
1.2.4 Immune System Modeling
1.3 Market by Application
1.3.1 Global Immunoinformatics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Allergy Prediction Databases
1.3.3 Analysis Resource Database
1.3.4 International Immunogenetics System
1.3.5 The Ontology of Immune Epitopes
1.3.6 Immune Epitope Database
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immunoinformatics Market Perspective (2017-2028)
2.2 Immunoinformatics Growth Trends by Region
2.2.1 Immunoinformatics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Immunoinformatics Historic Market Size by Region (2017-2022)
2.2.3 Immunoinformatics Forecasted Market Size by Region (2023-2028)
2.3 Immunoinformatics Market Dynamics
2.3.1 Immunoinformatics Industry Trends
2.3.2 Immunoinformatics Market Drivers
2.3.3 Immunoinformatics Market Challenges
2.3.4 Immunoinformatics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunoinformatics Players by Revenue
3.1.1 Global Top Immunoinformatics Players by Revenue (2017-2022)
3.1.2 Global Immunoinformatics Revenue Market Share by Players (2017-2022)
3.2 Global Immunoinformatics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunoinformatics Revenue
3.4 Global Immunoinformatics Market Concentration Ratio
3.4.1 Global Immunoinformatics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunoinformatics Revenue in 2021
3.5 Immunoinformatics Key Players Head office and Area Served
3.6 Key Players Immunoinformatics Product Solution and Service
3.7 Date of Enter into Immunoinformatics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunoinformatics Breakdown Data by Type
4.1 Global Immunoinformatics Historic Market Size by Type (2017-2022)
4.2 Global Immunoinformatics Forecasted Market Size by Type (2023-2028)
5 Immunoinformatics Breakdown Data by Application
5.1 Global Immunoinformatics Historic Market Size by Application (2017-2022)
5.2 Global Immunoinformatics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Immunoinformatics Market Size (2017-2028)
6.2 North America Immunoinformatics Market Size by Country (2017-2022)
6.3 North America Immunoinformatics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Immunoinformatics Market Size (2017-2028)
7.2 Europe Immunoinformatics Market Size by Country (2017-2022)
7.3 Europe Immunoinformatics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunoinformatics Market Size (2017-2028)
8.2 Asia-Pacific Immunoinformatics Market Size by Country (2017-2022)
8.3 Asia-Pacific Immunoinformatics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Immunoinformatics Market Size (2017-2028)
9.2 Latin America Immunoinformatics Market Size by Country (2017-2022)
9.3 Latin America Immunoinformatics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunoinformatics Market Size (2017-2028)
10.2 Middle East & Africa Immunoinformatics Market Size by Country (2017-2022)
10.3 Middle East & Africa Immunoinformatics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 EpiVax
11.1.1 EpiVax Company Detail
11.1.2 EpiVax Business Overview
11.1.3 EpiVax Immunoinformatics Introduction
11.1.4 EpiVax Revenue in Immunoinformatics Business (2017-2022)
11.1.5 EpiVax Recent Development
11.2 Novozymes Biopharma
11.2.1 Novozymes Biopharma Company Detail
11.2.2 Novozymes Biopharma Business Overview
11.2.3 Novozymes Biopharma Immunoinformatics Introduction
11.2.4 Novozymes Biopharma Revenue in Immunoinformatics Business (2017-2022)
11.2.5 Novozymes Biopharma Recent Development
11.3 ioGenetics
11.3.1 ioGenetics Company Detail
11.3.2 ioGenetics Business Overview
11.3.3 ioGenetics Immunoinformatics Introduction
11.3.4 ioGenetics Revenue in Immunoinformatics Business (2017-2022)
11.3.5 ioGenetics Recent Development
11.4 International Society of Vaccines
11.4.1 International Society of Vaccines Company Detail
11.4.2 International Society of Vaccines Business Overview
11.4.3 International Society of Vaccines Immunoinformatics Introduction
11.4.4 International Society of Vaccines Revenue in Immunoinformatics Business (2017-2022)
11.4.5 International Society of Vaccines Recent Development
11.5 IMGT
11.5.1 IMGT Company Detail
11.5.2 IMGT Business Overview
11.5.3 IMGT Immunoinformatics Introduction
11.5.4 IMGT Revenue in Immunoinformatics Business (2017-2022)
11.5.5 IMGT Recent Development
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Detail
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Immunoinformatics Introduction
11.6.4 Dassault Systemes Revenue in Immunoinformatics Business (2017-2022)
11.6.5 Dassault Systemes Recent Development
11.7 Certara
11.7.1 Certara Company Detail
11.7.2 Certara Business Overview
11.7.3 Certara Immunoinformatics Introduction
11.7.4 Certara Revenue in Immunoinformatics Business (2017-2022)
11.7.5 Certara Recent Development
11.8 Chemical Computing Group
11.8.1 Chemical Computing Group Company Detail
11.8.2 Chemical Computing Group Business Overview
11.8.3 Chemical Computing Group Immunoinformatics Introduction
11.8.4 Chemical Computing Group Revenue in Immunoinformatics Business (2017-2022)
11.8.5 Chemical Computing Group Recent Development
11.9 Compugen
11.9.1 Compugen Company Detail
11.9.2 Compugen Business Overview
11.9.3 Compugen Immunoinformatics Introduction
11.9.4 Compugen Revenue in Immunoinformatics Business (2017-2022)
11.9.5 Compugen Recent Development
11.10 Genedata AG
11.10.1 Genedata AG Company Detail
11.10.2 Genedata AG Business Overview
11.10.3 Genedata AG Immunoinformatics Introduction
11.10.4 Genedata AG Revenue in Immunoinformatics Business (2017-2022)
11.10.5 Genedata AG Recent Development
11.11 Insilico Biotechnology AG
11.11.1 Insilico Biotechnology AG Company Detail
11.11.2 Insilico Biotechnology AG Business Overview
11.11.3 Insilico Biotechnology AG Immunoinformatics Introduction
11.11.4 Insilico Biotechnology AG Revenue in Immunoinformatics Business (2017-2022)
11.11.5 Insilico Biotechnology AG Recent Development
11.12 Leadscope Inc
11.12.1 Leadscope Inc Company Detail
11.12.2 Leadscope Inc Business Overview
11.12.3 Leadscope Inc Immunoinformatics Introduction
11.12.4 Leadscope Inc Revenue in Immunoinformatics Business (2017-2022)
11.12.5 Leadscope Inc Recent Development
11.13 Nimbus Discovery
11.13.1 Nimbus Discovery Company Detail
11.13.2 Nimbus Discovery Business Overview
11.13.3 Nimbus Discovery Immunoinformatics Introduction
11.13.4 Nimbus Discovery Revenue in Immunoinformatics Business (2017-2022)
11.13.5 Nimbus Discovery Recent Development
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Detail
11.14.2 Strand Life Sciences Business Overview
11.14.3 Strand Life Sciences Immunoinformatics Introduction
11.14.4 Strand Life Sciences Revenue in Immunoinformatics Business (2017-2022)
11.14.5 Strand Life Sciences Recent Development
11.15 Schrodinger
11.15.1 Schrodinger Company Detail
11.15.2 Schrodinger Business Overview
11.15.3 Schrodinger Immunoinformatics Introduction
11.15.4 Schrodinger Revenue in Immunoinformatics Business (2017-2022)
11.15.5 Schrodinger Recent Development
11.16 Simulation Plus
11.16.1 Simulation Plus Company Detail
11.16.2 Simulation Plus Business Overview
11.16.3 Simulation Plus Immunoinformatics Introduction
11.16.4 Simulation Plus Revenue in Immunoinformatics Business (2017-2022)
11.16.5 Simulation Plus Recent Development
11.17 Rosa & Co
11.17.1 Rosa & Co Company Detail
11.17.2 Rosa & Co Business Overview
11.17.3 Rosa & Co Immunoinformatics Introduction
11.17.4 Rosa & Co Revenue in Immunoinformatics Business (2017-2022)
11.17.5 Rosa & Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Immunoinformatics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Cancer Diagnosis & Therapy
Table 3. Key Players of Reverse Vaccinology
Table 4. Key Players of Immune System Modeling
Table 5. Global Immunoinformatics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Immunoinformatics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Immunoinformatics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Immunoinformatics Market Share by Region (2017-2022)
Table 9. Global Immunoinformatics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Immunoinformatics Market Share by Region (2023-2028)
Table 11. Immunoinformatics Market Trends
Table 12. Immunoinformatics Market Drivers
Table 13. Immunoinformatics Market Challenges
Table 14. Immunoinformatics Market Restraints
Table 15. Global Immunoinformatics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Immunoinformatics Market Share by Players (2017-2022)
Table 17. Global Top Immunoinformatics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunoinformatics as of 2021)
Table 18. Ranking of Global Top Immunoinformatics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Immunoinformatics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Immunoinformatics Product Solution and Service
Table 22. Date of Enter into Immunoinformatics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immunoinformatics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Immunoinformatics Revenue Market Share by Type (2017-2022)
Table 26. Global Immunoinformatics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Immunoinformatics Revenue Market Share by Type (2023-2028)
Table 28. Global Immunoinformatics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Immunoinformatics Revenue Market Share by Application (2017-2022)
Table 30. Global Immunoinformatics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Immunoinformatics Revenue Market Share by Application (2023-2028)
Table 32. North America Immunoinformatics Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Immunoinformatics Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Immunoinformatics Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Immunoinformatics Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Immunoinformatics Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Immunoinformatics Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Immunoinformatics Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Immunoinformatics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Immunoinformatics Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Immunoinformatics Market Size by Country (2023-2028) & (US$ Million)
Table 42. EpiVax Company Detail
Table 43. EpiVax Business Overview
Table 44. EpiVax Immunoinformatics Product
Table 45. EpiVax Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 46. EpiVax Recent Development
Table 47. Novozymes Biopharma Company Detail
Table 48. Novozymes Biopharma Business Overview
Table 49. Novozymes Biopharma Immunoinformatics Product
Table 50. Novozymes Biopharma Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 51. Novozymes Biopharma Recent Development
Table 52. ioGenetics Company Detail
Table 53. ioGenetics Business Overview
Table 54. ioGenetics Immunoinformatics Product
Table 55. ioGenetics Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 56. ioGenetics Recent Development
Table 57. International Society of Vaccines Company Detail
Table 58. International Society of Vaccines Business Overview
Table 59. International Society of Vaccines Immunoinformatics Product
Table 60. International Society of Vaccines Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 61. International Society of Vaccines Recent Development
Table 62. IMGT Company Detail
Table 63. IMGT Business Overview
Table 64. IMGT Immunoinformatics Product
Table 65. IMGT Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 66. IMGT Recent Development
Table 67. Dassault Systemes Company Detail
Table 68. Dassault Systemes Business Overview
Table 69. Dassault Systemes Immunoinformatics Product
Table 70. Dassault Systemes Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 71. Dassault Systemes Recent Development
Table 72. Certara Company Detail
Table 73. Certara Business Overview
Table 74. Certara Immunoinformatics Product
Table 75. Certara Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 76. Certara Recent Development
Table 77. Chemical Computing Group Company Detail
Table 78. Chemical Computing Group Business Overview
Table 79. Chemical Computing Group Immunoinformatics Product
Table 80. Chemical Computing Group Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 81. Chemical Computing Group Recent Development
Table 82. Compugen Company Detail
Table 83. Compugen Business Overview
Table 84. Compugen Immunoinformatics Product
Table 85. Compugen Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 86. Compugen Recent Development
Table 87. Genedata AG Company Detail
Table 88. Genedata AG Business Overview
Table 89. Genedata AG Immunoinformatics Product
Table 90. Genedata AG Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 91. Genedata AG Recent Development
Table 92. Insilico Biotechnology AG Company Detail
Table 93. Insilico Biotechnology AG Business Overview
Table 94. Insilico Biotechnology AG ImmunoinformaticsProduct
Table 95. Insilico Biotechnology AG Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 96. Insilico Biotechnology AG Recent Development
Table 97. Leadscope Inc Company Detail
Table 98. Leadscope Inc Business Overview
Table 99. Leadscope Inc ImmunoinformaticsProduct
Table 100. Leadscope Inc Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 101. Leadscope Inc Recent Development
Table 102. Nimbus Discovery Company Detail
Table 103. Nimbus Discovery Business Overview
Table 104. Nimbus Discovery ImmunoinformaticsProduct
Table 105. Nimbus Discovery Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 106. Nimbus Discovery Recent Development
Table 107. Strand Life Sciences Company Detail
Table 108. Strand Life Sciences Business Overview
Table 109. Strand Life Sciences ImmunoinformaticsProduct
Table 110. Strand Life Sciences Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 111. Strand Life Sciences Recent Development
Table 112. Schrodinger Company Detail
Table 113. Schrodinger Business Overview
Table 114. Schrodinger ImmunoinformaticsProduct
Table 115. Schrodinger Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 116. Schrodinger Recent Development
Table 117. Simulation Plus Company Detail
Table 118. Simulation Plus Business Overview
Table 119. Simulation Plus ImmunoinformaticsProduct
Table 120. Simulation Plus Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 121. Simulation Plus Recent Development
Table 122. Rosa & Co Company Detail
Table 123. Rosa & Co Business Overview
Table 124. Rosa & Co ImmunoinformaticsProduct
Table 125. Rosa & Co Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 126. Rosa & Co Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunoinformatics Market Share by Type: 2021 VS 2028
Figure 2. Cancer Diagnosis & Therapy Features
Figure 3. Reverse Vaccinology Features
Figure 4. Immune System Modeling Features
Figure 5. Global Immunoinformatics Market Share by Application in 2021 & 2028
Figure 6. Allergy Prediction Databases Case Studies
Figure 7. Analysis Resource Database Case Studies
Figure 8. International Immunogenetics System Case Studies
Figure 9. The Ontology of Immune Epitopes Case Studies
Figure 10. Immune Epitope Database Case Studies
Figure 11. Immunoinformatics Report Years Considered
Figure 12. Global Immunoinformatics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Immunoinformatics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Immunoinformatics Market Share by Region: 2021 VS 2028
Figure 15. Global Immunoinformatics Market Share by Players in 2021
Figure 16. Global Top Immunoinformatics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunoinformatics as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Immunoinformatics Revenue in 2021
Figure 18. North America Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Immunoinformatics Market Share by Country (2017-2028)
Figure 20. United States Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Immunoinformatics Market Share by Country (2017-2028)
Figure 24. Germany Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Immunoinformatics Market Share by Region (2017-2028)
Figure 32. China Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Immunoinformatics Market Share by Country (2017-2028)
Figure 40. Mexico Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Immunoinformatics Market Share by Country (2017-2028)
Figure 44. Turkey Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Immunoinformatics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. EpiVax Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 47. Novozymes Biopharma Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 48. ioGenetics Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 49. International Society of Vaccines Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 50. IMGT Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 51. Dassault Systemes Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 52. Certara Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 53. Chemical Computing Group Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 54. Compugen Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 55. Genedata AG Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 56. Insilico Biotechnology AG Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 57. Leadscope Inc Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 58. Nimbus Discovery Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 59. Strand Life Sciences Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 60. Schrodinger Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 61. Simulation Plus Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 62. Rosa & Co Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
EpiVax Novozymes Biopharma ioGenetics International Society of Vaccines IMGT Dassault Systemes Certara Chemical Computing Group Compugen Genedata AG Insilico Biotechnology AG Leadscope Inc Nimbus Discovery Strand Life Sciences Schrodinger Simulation Plus Rosa & Co